VIZIENT, INC. for VIZIENT INC

Health Issues HCR

Hospital Group Purchasing - Advocated in support of hospital group purchasing organizations and maintaining the GPO safe harbor. Coronavirus relief Efforts - Supported passage of several bills to provide economic stability, financial relief and regulatory flexibility for hospitals in response to the COVID-19 crisis. H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act. H.R. 6201 - Families First Coronavirus Response Act H.R. 748 - Coronavirus Aid, Relief and Economic Stability (CARES) Act Offered recommendations to avoid supply chain disruptions of personal protective equipment and essential medications and supplies for hospitals for treating patients with COVID-19. Supported additional flexibilities to increase access to compounded medications. Urged DEA to expand aggregate production quotas for essential medications. Prescription Drug Pricing - Monitored ongoing negotiations to reduce prescription drug prices. Engaged to clarify provisions in the House (H.R. 3) and Senate (S. 2543) drug pricing bills. 340B Drug Pricing Program - Supported maintaining adequate reimbursement for hospitals purchasing prescription drugs through the 340B Drug Pricing Program. Advocated for preserving the current structure of the program. Surprise Billing - Supported inclusion of provisions to provide for an independent dispute resolution process in legislation to address surprise bills (H.R. 3630; H.R. 2328; S. 1895). Rural Health Care Issues - Offered support for the following legislation that would make improvements to rural health care access: Critical Access Hospital Regulatory Relief (S. 586/H.R. 1041) Rural Hospital Regulatory Relief Act (S. 895/H.R. 3416) Rural Health Clinic Modernization Act (S. 1037/H.R. 2788) Telehealth Across State Lines Act (S. 2408/H.R.4900) CONNECT For Health Act (S. 2741/H.R.4932) Conrad State 30 and Physician Access Reauthorization Act (S. 948/H.R.2895)

Contacted: SENATE; Office of the Vice President of the United States; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA)

Bills named: H.R. 2328 (116th), S. 1895 (116th), S. 1037 (116th), S. 2408 (116th), S. 948 (116th), H.R. 4900 (116th), S. 2543 (116th), H.R. 748 (116th), H.R. 3416 (116th), S. 895 (116th), H.R. 6201 (116th), H.R. 2788 (116th), H.R. 4932 (116th), H.R. 3 (116th), S. 586 (116th), H.R. 3630 (116th), H.R. 2895 (116th), H.R. 6074 (116th), H.R. 1041 (116th), S. 2741 (116th)

Medicare/Medicaid MMM

Children's Hospital Graduate Medical Education - Urged Congress to increase funding for CHGME. Medicaid Disproportionate Share Hospital (DSH) Payments - Urged Congress to extend delay of implementation of Medicaid DSH payment cuts. Site-neutral Payments - Supported passage of the PLACE Act (H.R. 2552) which would reverse site-neutral payments cuts implemented by the Centers for Medicare and Medicaid Services. Resident Physician Shortage Reduction Act (S. 348) - Supported passage of the Resident Physician Shortage Reduction Act to support an increase in the number of Medicare-supported graduate medical education residents. Rural ACO Improvement Act (S. 2642/H.R. 5212) - Supported passage of the Rural ACO Improvement Act.

Contacted: HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Office of the Vice President of the United States; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: S. 348 (116th), S. 2642 (116th), H.R. 5212 (116th), H.R. 2552 (116th)